TRIPHASE

Pharmaceuticals
Dr. Shrilakshmi Desiraju
1994-99 1999-01 2001-08 2009
Ph. D.
Ph.D (Peptile Worked at Came Back to India
(Natural
Chemistry) NAEJA Founded Triphase
Product
IISc Bangalore Pharmaceuticals
Chemistry)
Ujjain

Co-founder & CEO Post Doctoral

MBA (Technology
Researcher at Eureca Moment
Triphase NCL Commercialization)
Came
Went to University of Alberta
Pharmaceuticals Canada
(Lactobacilus)
1998-99
2001 2006-08 2015
 About TRIPHASE Pharmaceuticals

Headquarter- Mysore, Karnataka (India)

Founder- Aditya Desiraju
Co-Founder- Shrilakshmi Desiraju

● Creating innovative products in the probiotics industry. Currently, the startup is researching
the use of probiotics in helping patients with diabetes and cancer.
● Led by professionals and accomplished scientists from the biotech and food industries
● Specializes in the development of high temperature stable probiotics and their application.
● Triphase has a Research & development facility and a dedicated manufacturing unit under
construction in Mysore
● The company looks forward to bring good and scientifically validated products for increasing
the health and wellness of the people.
 Year 2009 Aug 2018
Triphase Founded US, European, Canadian
Patent awarded
Pharmaceuticals
Journey

Oct 2018
June 2017 Bio Excellence award as
Raised Series A Funding emerging company 2018
from Govt of Karnataka

4
 PROBIOTICS
PROBIOTICS
AND ITS
BENEFITS Probiotics are a combination of live beneficial bacteria
and/or yeasts that naturally live in your body.
We constantly have both good and bad bacteria in
your body. When you get an infection, there’s more
bad bacteria, knocking your system out of
balance. Good bacteria helps eliminate extra bad
bacteria, returning the balance.

Common probiotics found in stores:

1. Lactobacillus
2. Bifidobacterium

5
Can Probiotics
be harmful?
The risk of harmful effects from probiotics is higher in people
with compromised immune system.

Possible harmful effects of probiotics include infections,

production of harmful substances from probiotic
microorganisms.

So, if you are considering a probiotic dietary

supplement,consult health care provider first.This is
specially important if you have already any health
issues

6
 PESTLE
POLITICAL
1) In pursuance of its policy towards
achieving greater self-reliance or
Atma Nirbhar Bharath, the govt
proposes to set up three bulk
drug parks in the country to make SOCIOLOGICAL
chemical compounds or APIs. 1) Demographic factors - The country’s
2) Reduce the industry’s reliance on population includes a sizable section
imports, particularly from China, of older people who consequently
for raw material requirements. require health care facilities.
2) Greater incidence of the so-called
ECONOMIC lifestyle diseases among a larger
1) Low cost of manufacturing. section of the population including
2) Steady inflow of Foreign Direct younger people.
Investment.
3) Favourable investments in Probiotic
sector
 PESTLE

TECHNOLOGICAL
1) Probiotic sector is still niche and
has a lot of growth to be seen.
2) High end culture of Temperature
resistant Lactobacillus not
possible in a large scale.
LEGAL
1) Regulations for the probiotic production and
release in India have been framed by regulatory
ENVIRONMENTAL bodies of ICMR, DBT, and FSSAI.
1) Genetic mutation in probiotic 2) Adherence to Convention on Biological diversity.
species can be detrimental to
human health and
environment as whole.
2) Protection of Biodiversity
through appropriate use of
biological resources.
 SWOT Analysis

STRENGTHS: WEAKNESS:
1. Strong research and development capabilities 1. High operating costs
2. Experienced management team 2. Stringent regulatory requirements
3. US and UK patented 3. Dependence on government funding

THREATS:
OPPORTUNITIES:
1. Intense competition from other pharmaceutical
1. Growing demand for probiotic in the market
companies
2. Advancements in technology and biotechnology
2. Regulatory hurdles and delay in approval
3. Increasing healthcare spending and government
spending
THANK
YOU